The use of antithymocyte globulin in myasthenia gravis
- PMID: 1087016
Item in Clipboard
The use of antithymocyte globulin in myasthenia gravis
Postgrad Med J.
1976.
Abstract
Antithymocyte globulin (ATG) has been used to treat three female patients with myastenia gravis. No other immunosuppressive agent was used. All three cases responded favourably to ATG therapy. This suggest that further work should be undertaken in this field though the condition itself is extremely variable and this study was not controlled.
Similar articles
-
Antithymocyte antiserum therapy in myasthenia gravis.Postgrad Med J. 1976;52(5 Suppl):112-7. Postgrad Med J. 1976. PMID: 1087017
-
Myasthenia gravis treated with purified antithymocyte antiserum.Neurology. 1979 Jan;29(1):112-6. doi: 10.1212/wnl.29.1.112. Neurology. 1979. PMID: 311448
-
Myasthenia gravis: ALG treatment of seriously ill patients.Eur Neurol. 1975;13(5):422-32. doi: 10.1159/000114698. Eur Neurol. 1975. PMID: 1080463
-
[Treatment of aplastic anemia with antithymocyte globulin, Lymphoser Berna].Rinsho Ketsueki. 1993 Jul;34(7):815-20. Rinsho Ketsueki. 1993. PMID: 8360986 Japanese.
-
[Problems posed by the use of anti-thymocyte globulins in myasthenia (apropos of the treatment of 2 cases of myasthenia gravis)].Mars Med. 1972;109(6):395-407. Mars Med. 1972. PMID: 4538918 French. No abstract available.